Reborna Biosciences

company

About

Reborna Biosciences is a research and development start-up focusing on the field of rare genetic diseases.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
¥256M
Industries
Biotechnology,Health Care
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients suffering from rare genetic diseases including spinal muscular atrophy.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥256M
Reborna Biosciences has raised a total of ¥256M in funding over 2 rounds. Their latest funding was raised on Jun 25, 2018 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 25, 2018 Seed ¥256M 1 Takeda Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Reborna Biosciences is funded by 1 investors. Takeda are the most recent investors.
Investor Name Lead Investor Funding Round
Takeda Yes Seed